MAYO CLINIC
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
Phase 2
Completed
- Conditions
- Stage III Prostate CancerProstate AdenocarcinomaStage IV Prostate CancerProstate CarcinomaRecurrent Prostate Carcinoma
- Interventions
- Drug: BicalutamideDrug: FlutamideDrug: Goserelin AcetateDrug: IpilimumabDrug: Leuprolide AcetateOther: Pharmacological Study
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 112
- Registration Number
- NCT00170157
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Precision of the Magnetocardiographer for Data Aquision and Analysis.
Phase 3
Completed
- Conditions
- Myocardial Ischemia
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2011-02-15
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 12
- Registration Number
- NCT00170014
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Effects of Motivational Interviewing on Self-Efficacy and Standardized Low Back Pain Outcomes in Patients With Chronic Back Pain"
Not Applicable
Completed
- Conditions
- Chronic Low Back Pain
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2010-01-28
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 6
- Registration Number
- NCT00170118
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation
Phase 2
Completed
- Conditions
- Transplantation, Liver
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-05-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT00166556
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
A Randomized Clinical Trial of Metoprolol in Participants With Mitral Regurgitation.
Phase 4
Completed
- Conditions
- Heart Valve Diseases
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2008-07-24
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT00166400
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent
Not Applicable
Completed
- Conditions
- Ureteral Obstruction
- Interventions
- Device: JJ StentDevice: Memokath 051 Ureteral Stent
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2014-07-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 29
- Registration Number
- NCT00166361
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Efficacy of CC-5013 (Revlimid or Lenalidomide) in Patients With Primary Systemic Amyloidosis
Phase 2
Completed
- Conditions
- Amyloidosis
- Interventions
- Drug: CC-5013
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-05-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 38
- Registration Number
- NCT00166413
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Comparing Two Ways of Controlling Blood Sugar With Insulin in Patients Admitted to the Intensive Care Unit
Not Applicable
Completed
- Conditions
- Critical IllnessHyperglycemia
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-04-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 238
- Registration Number
- NCT00166491
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1
Phase 3
Completed
- Conditions
- Complex Regional Pain Syndrome, Type 1
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 7
- Registration Number
- NCT00166452
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Stage IV Colorectal CA ALIMTA
Phase 1
Completed
- Conditions
- Locally Advanced Unresectable or Stage IV Colorectal Cancer
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-03-14
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 200
- Registration Number
- NCT00166465
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath